Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis
Journal of Affective Disorders · 2023-06 · 330 · 227-238
DOI: 10.1016/j.jad.2023.02.152 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Affective Disorders, 2023-06. Verfasst von Debora de A Simoes Moreira und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Sciences College of Santos, Lusíada Foundation (UNILUS), Santos, SP, Brazil. Hauptthemen laut MEDLINE: Ketamine, Major Depressive Disorder, Electroconvulsive Therapy. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIMH.
Abstract (Originalsprache)
BACKGROUND: ECT is considered the fastest and most effective treatment for TRD. Ketamine seems to be an attractive alternative due to its rapid-onset antidepressant effects and impact on suicidal thoughts. This study aimed to compare efficacy and tolerability of ECT and ketamine for different depression outcomes (PROSPERO/CRD42022349220). METHODS: We searched MEDLINE, Web of Science, Embase, PsycINFO, Google Scholar, Cochrane Library and trial registries, which were the ClinicalTrials.gov and the World Health Organization's International Clinical Trials Registry Platform, without restrictions on publication date. SELECTION CRITERIA: randomized controlled trials or cohorts comparing ketamine versus ECT in patients with TRD. RESULTS: Eight studies met the inclusion criteria (of 2875 retrieved). Random-effects models comparing ketamine and ECT regarding the following outcomes were conducted: a) reduction of depressive symptoms severity through scales, g = -0.12, p = 0.68; b) response to therapy, RR = 0.89, p = 0.51; c) reported side-effects: dissociative symptoms, RR = 5.41, p = 0.06; nausea, RR = 0.73, p = 0.47; muscle pain, RR = 0.25, p = 0.02; and headache, RR = 0.39, p = 0.08. Influential & subgroup analyses were performed. LIMITATIONS: Methodological issues with high risk of bias in some of the source material, reduced number of eligible studies with high in-between heterogeneity and small sample sizes. CONCLUSION: Our study showed no evidence to support the superiority of ketamine over ECT for severity of depressive symptoms and response to therapy. Regarding side effects, there was a statistically significant decreased risk of muscle pain in patients treated with ketamine compared to ECT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Sciences College of Santos, Lusíada Foundation (UNILUS), Santos, SP, Brazil.
- Federal University of Paraná (UFPR), Curitiba, PR, Brazil.
- University of Pernambuco (UPE), Recife, PE, Brazil.
- Federal University of Santa Catarina (UFSC), Florianópolis, SC, Brazil.
- Translational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth Houston), Houston, TX, USA; Center…
Förderung
- NIMH NIH HHS
- NIMH
Zitieren
APA
de A Simoes Moreira, D., Gauer, L. E., Teixeira, G., Fonseca da Silva, A. C., Cavalcanti, S., & Quevedo, J. (2023). Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis. Journal of Affective Disorders, 330, 227-238. https://doi.org/10.1016/j.jad.2023.02.152
Vancouver
de A Simoes Moreira D, Gauer LE, Teixeira G, Fonseca da Silva AC, Cavalcanti S, Quevedo J. Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis. Journal of Affective Disorders. 2023;330:227-238. doi:10.1016/j.jad.2023.02.152
BibTeX
@article{deASimoesMoreira2023,
author = {de A Simoes Moreira, Debora and Gauer, Luís Eduardo and Teixeira, Guilherme and Fonseca da Silva, Amanda Carolina and Cavalcanti, Stefanie and Quevedo, João},
title = {Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis},
journal = {Journal of Affective Disorders},
year = {2023},
volume = {330},
pages = {227--238},
doi = {10.1016/j.jad.2023.02.152}
}
EUVIMED